Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05361421 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Oct 15, 2025 to Oct 15, 2027v4 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Secondary endpoints: 2 to 21
    • Site details revised
    • Eligibility criteria expanded, about 1 word
  2. Primary completion date: Oct 2025 to Oct 15, 2025
    • Study completion date: Oct 2027 to Oct 15, 2027
    • Start date: Sep 14, 2022 to Jul 19, 2022
    v3
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Start date changed from estimate of Jun 2022 to Sep 14, 2022
    • Eligibility criteria shortened, about 8 words
    • Site details revised
    • Secondary endpoints expanded, about 4 words
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Yonsei University
239 trials monitored
See 2 trials at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Although there have been studies regarding intensive lowering of low-density lipoprotein (LDL)-cholesterol with high intensity statins in patients with cardiovascular disease, elderly patients were either excluded or accounted only a small portion of study subjects. Therefore, this study sought to compare the clinical outcomes according to the LDL-cholesterol therapy strategy (intensive targeting \[LDL-cholesterol goal of \<55mg/dL\] vs. conventional therapy \[moderate intensity statin therapy\]) in elderly patients with ≥75 years and documented cardiovascular disease.
Trial Details
NCT Number NCT05361421
Lead Sponsor Yonsei University
Conditions
(from sponsor)		 Cardiovascular Disease
Related terms Cardiovascular Diseases
Enrollment 1,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov